Implications of dopaminergic medication withdrawal in Parkinson’s disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Link
https://link.springer.com/content/pdf/10.1007/s00702-021-02389-x.pdf
Reference81 articles.
1. Antonini A, Leta V, Teo J, Ray Chaudhuri K (2020) Outcome of Parkinson’s disease patients affected by COVID-19. Movem Disord 35(6):905–908. https://doi.org/10.1002/mds.28104
2. Barbosa P, Djamshidian A, Lees AJ, Warner TT (2018) The outcome of dopamine dysregulation syndrome in Parkinson’s disease: a retrospective postmortem study. Movement Disorders Clinical Practice 5(5):519–522. https://doi.org/10.1002/mdc3.12671
3. Bertholo AP, França C, Fiorini WS, Barbosa ER, Cury RG (2020) Medical management after subthalamic stimulation in parkinson’s disease: a phenotype perspective. Arq Neuropsiquiatr 78(4):230–237. https://doi.org/10.1590/0004-282X20190188
4. Bhidayasiri R, Garcia PJ, Ruiz, and Tove Henriksen (2016) Practical management of adverse events related to apomorphine therapy. Parkinsonism Relat Disord 33 Suppl 1(December):S42–S48. https://doi.org/10.1016/j.parkreldis.2016.11.017
5. Binde CD, Tvete IF, Gåsemyr J, Natvig B, Klemp M (2018) A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson’s disease. Br J Clin Pharmacol 84(9):1917–1927. https://doi.org/10.1111/bcp.13651
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Terminal Care in Parkinson’s Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort;Journal of Parkinson's Disease;2024-01-23
2. Radiomics for Parkinson's disease classification using advanced texture-based biomarkers;MethodsX;2023-12
3. The Neuroprotective Effect of Isotetrandrine on Parkinson’s Disease via Anti-Inflammation and Antiapoptosis In Vitro and In Vivo;Parkinson's Disease;2023-10-10
4. Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience;Journal of Neural Transmission;2023-09-01
5. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report;Frontiers in Psychiatry;2023-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3